Oscar Health insider Mario Schlosser sells 750K shares
Oscar Health, Inc. (OSCR) director Mario Schlosser reported an option exercise-and-sale sequence involving Class A and Class B common stock on August 27–28, 2026.
Rhea-AI Filing Summary
Oscar Health, Inc. (OSCR) director Mario Schlosser reported an option exercise-and-sale sequence involving Class A and Class B common stock on August 27–28, 2026. He exercised fully vested stock options with a $9.75 exercise price, covering in total 750,000 shares of Class B common stock, which were then converted into Class A common stock on a one-to-one basis.
Across the two days, Schlosser reported open-market sales of 750,000 shares of Class A common stock, including 600,000 shares at a weighted average price of $30.34 (range $29.98–$30.73) and 150,000 shares at a weighted average price of $30.79 (range $30.59–$30.89). The exercised stock options expire on December 16, 2029. Separate from these transactions, trusts associated with Schlosser hold Class B common stock convertible into an aggregate of 1,104,999 shares of Class A common stock, and he disclaims beneficial ownership of those trust-held shares except to the extent of any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F5 | 150,000 | $0.00 | $0.00 |
| Exercise | Class B Common Stock F1 | 150,000 | $9.75 | $1.46M |
| Conversion | Class B Common Stock F1 | 150,000 | $0.00 | $0.00 |
| Conversion | Class A Common Stock F1, F2 | 150,000 | -- | -- |
| Sale | Class A Common Stock F4, F2 | 150,000 | $30.79 | $4.62M |
| Exercise | Stock Option (Right to Buy) F5 | 600,000 | $0.00 | $0.00 |
| Exercise | Class B Common Stock F1 | 600,000 | $9.75 | $5.85M |
| Conversion | Class B Common Stock F1 | 600,000 | $0.00 | $0.00 |
| Conversion | Class A Common Stock F1, F2 | 600,000 | -- | -- |
| Sale | Class A Common Stock F3, F2 | 600,000 | $30.34 | $18.20M |
| holding | Class B Common Stock F1, F6 | -- | -- | -- |
| holding | Class B Common Stock F1, F6 | -- | -- | -- |
| holding | Class B Common Stock F1, F6 | -- | -- | -- |
Footnotes (6)
- F1. The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.
- F2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.98 to $30.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.59 to $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- F5. The stock option is fully vested and exercisable, and expires on December 16, 2029.
- F6. Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any.
Key Figures
Key Terms
weighted average price financial
derivative security financial
beneficial ownership financial
pecuniary interest financial
convertible financial
FAQ
What did Mario Schlosser report in this Form 4 for OSCR?
What options did Mario Schlosser exercise in this OSCR filing?
What indirect holdings in OSCR does Mario Schlosser report through trusts?
Were the reported OSCR stock sales made under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.